Tonix Pharmaceuticals (TNXP) Misses Q2 EPS by 8c

Tonix Pharmaceuticals (NASDAQ: TNXP) reported Q2 EPS of ($0.73), $0.08 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Tonix Pharmaceuticals (TNXP) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Streamflation drives 39% of Americans to cancel streaming in 6 months
• Citi lowers Hancock Whitney price target to $86